STD Rates in New York
CDC surveillance data for New York covering chlamydia, gonorrhea, syphilis, and HIV — with 15-year trends, city-level context, and national comparisons.
New York ranks 9th in the country for combined STD burden — a position that might surprise people who assume New York City skews everything and the state as a whole is an outlier. It does rank in the top ten, but the combined rate of 808.8 per 100,000 people is 27% above the US median, driven less by any single spike than by years of steady, compounding growth across all three major infections. What's notable isn't the ranking itself. It's how the state got there.
Chlamydia is the quietest part of the story, which is saying something given the numbers. The 2023 rate of 558.4 per 100,000 sits 18.5% above the national median of 471.3 — but after peaking near 640 in 2019 and dropping during the pandemic, the rate has been climbing back steadily. It's not at its prior peak yet. Whether it gets there depends on factors that are hard to predict, including testing volume and access. What the trend makes clear is that chlamydia never really receded in New York — it paused.
Gonorrhea is the sharper story. The rate has risen 168% since 2008 — from 87.9 to 235.6 per 100,000 — and it's now 55% above the national median of 152.2. That kind of sustained climb over 15 years doesn't look like a statistical artifact. Syphilis, by contrast, actually pulled back in 2023: the rate fell from 18.3 to 14.8, a 19% drop year-over-year. That's now exactly at the national median — a notable change from recent years when New York ran above it. Whether that decline holds is a different question.
HIV data tells a slower, more hopeful story. New diagnoses in New York fell from 2,753 in 2017 to 2,221 in 2022 — a 19% reduction over five years, with a sharp dip in 2020 that almost certainly reflects pandemic-related disruptions to testing rather than a true drop in transmission. The state still records over 2,000 new HIV diagnoses annually, concentrated heavily in New York City but present across the state including Buffalo and Rochester. If you're in any of those cities and haven't been tested recently, the numbers here are a reasonable prompt to change that.
STD Trends in New York
New York's chlamydia rate has been above the national median for years, but the more telling detail is the trajectory. After peaking at 640.6 per 100,000 in 2019, the rate dropped during the pandemic and has been climbing back — reaching 558.4 in 2023, up 6% from 2022. The long-run rise since 2008 is about 23%, modest compared to gonorrhea, but the post-pandemic rebound suggests the ceiling hasn't been reached.
Gonorrhea is where New York's numbers get harder to dismiss. The rate has risen 168% since 2008 — from 87.9 to 235.6 per 100,000 — and now sits 55% above the national median of 152.2. Unlike chlamydia, gonorrhea didn't meaningfully dip during the pandemic; it kept climbing through 2020 and beyond, suggesting the rise reflects structural transmission patterns, not just testing fluctuations.
Syphilis in New York took a notable turn in 2023: after years of steady increases that pushed the rate above the national median, it dropped 19% year-over-year — from 18.3 to 14.8 per 100,000. That now puts New York exactly at the US median, which is a meaningful shift from where the state was sitting as recently as 2021 and 2022. Whether that represents a genuine reversal or a one-year fluctuation remains to be seen.
New York's HIV diagnosis rate has declined over the most recent five years of available data, falling from 16.5 per 100,000 in 2017 to 13.2 in 2022. The 2020 dip to 11.7 almost certainly reflects disrupted access to testing during the pandemic rather than an actual reduction in new infections. Even with the longer-term decline, New York still recorded 2,221 new HIV diagnoses in 2022 — one of the highest totals of any state.
Know your status — get tested today
Same-day testing at 4,500+ locations. No appointment needed. Results in 1–3 days.
New York vs National Average
Comparing 2023 rates against the U.S. median across all 50 states.
| Infection | New York | US Median | Difference |
|---|---|---|---|
| Chlamydia | 558.4 | 471.3 | 18.5% above |
| Gonorrhea | 235.6 | 152.2 | 54.8% above |
| Syphilis (P&S) | 14.8 | 14.8 | 0% below |
What the numbers mean — and what to do about them
New York's combined STD rate of 808.8 per 100,000 translates to more than 158,000 diagnosed cases of chlamydia, gonorrhea, and syphilis in a single year. That's across a state of nearly 20 million people — so it's not a crisis affecting every household, but it's concentrated enough in certain communities and cities that the risk is real and unevenly distributed. The state's 9th-place national ranking means it consistently outpaces most of the country, and has for years.
The trend that carries the most clinical weight is gonorrhea's 168% rise since 2008. Gonorrhea is increasingly resistant to some antibiotic treatments, and because the infection is often asymptomatic — especially in women — people can transmit it for weeks or months without knowing. That's how rates compound quietly over time. Chlamydia carries the same risk: an estimated 70-80% of cases produce no symptoms, which means the 109,000 diagnosed cases in 2023 are almost certainly an undercount of true prevalence.
If you live in New York — whether in New York City, Buffalo, Rochester, or anywhere in between — the case for routine testing isn't abstract. Gonorrhea in this state is 55% above the national median, and chlamydia has been climbing back toward its 2019 peak. STDTest.com can show you exactly where to get tested near you, today. New York's numbers didn't get here by accident, and they won't improve without people actually knowing their status.
WHO SHOULD GET TESTED
Sexually active New Yorkers under 25 face the highest chlamydia burden nationally, and New York's rate — 18.5% above the US median — reflects that. Men who have sex with men are at elevated risk given the state's HIV diagnosis volume (2,221 new cases in 2022) and gonorrhea rates well above the national median. Anyone with a new or multiple partners should not assume they're in the clear based on symptoms alone.
HOW OFTEN
Annual testing is a reasonable baseline for most sexually active adults in New York. Given gonorrhea's sustained climb — up 168% since 2008 with no sign of plateauing — people with higher exposure risk should consider testing every 3 to 6 months. New York City's density and HIV burden make more frequent testing especially relevant for residents there.
WHAT TO EXPECT
Most STD tests involve a urine sample, a swab, or a blood draw — often all three at once, depending on what you're being tested for. Results typically come back within a few days. Testing is confidential, and many locations in New York City, Buffalo, and Rochester offer low-cost or free options. The appointment usually takes under 30 minutes.
Find a clinic near you
4,500+ testing locations nationwide. 100% confidential. Most insurance accepted.
